Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
filingDate |
2009-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ba84fba4862ed40748f80da68b399b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd096685a426b0a4fd87293688bed191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78a3619f7cef7e67b23a8a422614dd74 |
publicationDate |
2011-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2010013265-A |
titleOfInvention |
ANTI-CD8 ANTIBODIES BLOCK PRIMING OF CYTOTOXIC EFFECTS AND LEAD TO GENERATION OF CD8 + T REGULATORY CELLS. |
abstract |
The present invention includes compositions and methods for inducing tolerance in a subject in need thereof, which comprises providing the subject with an effective amount of an anti-CD8 antibody sufficient to induce immune tolerance of CD8 + T cell to allogeneic antigens. |
priorityDate |
2008-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |